Tag: Calpain Therapeutics
Company developing cataract-fighting drug wins 2011 Enterprize competition
A company pioneering a drug to delay cataracts from forming or slow their growth has won this year's $100,000 Enterprize competition. Adelaide-based Calpain Therapeutics' victory was announced earlier this month by University of Queensland Business School, which has run Australia's richest business-plan contest since 2000.
Adelaide startup takes out UQ Business School’s $100,000 Enterprize competition
On World Sight Day, judges of the University of Queensland (UQ) Business School’s $100,000 Enterprize competition finals voted resoundingly for an innovation that could control the world’s single largest cause of blindness – cataract, a clouding of the eye’s lens among older populations. Calpain Therapeutics, an Adelaide startup that has developed a drug that can slow the onset of cataract, won the nation’s richest business plan competition, ahead of four others shortlisted.
